semaglutide lilly Eli slashes obesity drug price by up to 20% Novo Scores Cardio Wins But

Miller, [email protected], orcid.org/0000-0002-4743-8187 These authors have contributed equally to this work and share first authorship This article was submitted to Drug Metabolism and Transport, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

That broader availability though still limited may be what's driving GLP-1 usage higher overall

study in Diabetes, Obesity, and Metabolism , people taking GLP-1s regained two-thirds of the weight theyd lost while on the drug (and reversed any improvements in their heart health to boot)

Nishimura M., Ohkawara T., Nakagawa T., Muro T., Sato Y., Satoh H., Kobori M., Nishihira J., A randomized, double-blinded, placebo-controlled study evaluating the effects of quercetin-rich onions on cognitive function in elderly subjects

Published RCT data on relevant endpoints